StudyRareStudyRare

Chronic granulomatous disease (CGD)

Log in to star

Last updated Nov 3, 2026

Log in to add personal notes on this page.

A boy has recurrent abscesses (skin, liver, lungs) and lymphadenitis. Cultures grow catalase-positive organisms (Staph aureus, Aspergillus). DHR flow cytometry is abnormal.

XLR (CYBB, ~66%) or AR (NCF1 20%, CYBA 7%, NCF2 7%, NCF4 <1%, CYBC1 rare); each gene encodes a part of the phagocyte NADPH oxidase, and pathogenic variants leave that part absent or much reduced.

  • NADPH oxidase deficiency

NADPH oxidase lets phagocytes (neutrophils, monocytes, macrophages, eosinophils) make the reactive oxygen species that kill bacteria and fungi. Its parts are gp91phox (CYBB) and p22phox (CYBA) in the membrane; EROS (CYBC1), needed to assemble those two; and p47phox (NCF1), p67phox (NCF2), and p40phox (NCF4) in the cytoplasm. A variant in any one gene leaves its protein absent or much reduced, the oxidase makes no reactive oxygen species, and select microbes evade killing. The disease also brings dysregulated inflammatory responses, which produce granulomas and colitis.

Residual superoxide production correlates most directly with survival. Hypomorphic variants with partial function (seen in some AR CGD and in protein-positive X-linked CGD) give a milder, later course. In CYBB, nonsense variants and deletions are highly deleterious and associated with poorer outcomes; missense variants in amino acids 1 to 309 usually leave enough superoxide for good survival, whereas variants from residue 310 on disrupt the FAD- and NADPH-binding domains. Heterozygous females are at substantial risk for inflammatory conditions, and below 20% DHR-positive neutrophils (skewed X-inactivation) also for CGD-specific infections.

The common NCF1 variants arise by gene conversion with flanking pseudogenes, so sequencing can miss them.

  • Recurrent infections with catalase-positive organisms (Staph, Serratia, Aspergillus, Nocardia)
  • Abscesses (skin, liver, lung, lymph nodes)
  • Granuloma formation
  • Inflammatory complications (GI, GU obstruction)
  • Abnormal DHR or NBT test
  • Dihydrorhodamine (DHR123) flow cytometry: measures the oxidative burst; the more sensitive and quantitative first-line functional test
  • Nitroblue tetrazolium (NBT) slide test: older qualitative assay; neutrophils fail to reduce dye to blue formazan
  • Confirmatory molecular testing of CYBB, CYBA, NCF1, NCF2, NCF4 to define genotype and inheritance
  • Carrier testing of at-risk female relatives (X-linked CYBB shows a mosaic/bimodal DHR pattern)
  • Prophylactic antibiotics/antifungals, interferon-gamma, HSCT

The name is descriptive. Look for a patient with multiple chronic infections.

Patients may have acne-like bumps on their skin (granulomas), which reflect localized areas of inflammation. These inflammatory "bumps" can also be found in the internal organs (lungs, lymph nodes, bone).

Reference Links